HSPA1A and breast cancer: Similarly shRNA-mediated depletion of HSPA1 increased toxicity of BTZ in bladder cancer cells61, and the combination of HSPAs inhibitor JG-98 and proteasome inhibitor MG-132 has synergistic effect in breast cancer cells41.